Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 60.0 | 67 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 43.5 | 70 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 53.0 | 56 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 50.0 | 86 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 59.5 | 58 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 88.5 | 66 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 99.0 | 56 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 96.0 | 63 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 101.0 | 67 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 103.0 | 53 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 94.0 | 87 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 99.0 | 59 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | Eotaxin | 101.0 | 59 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | Eotaxin | 97.5 | 66 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | Eotaxin | 118.0 | 65 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | Eotaxin | 75.0 | 60 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | Eotaxin | 90.0 | 78 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | Eotaxin | 98.0 | 74 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | Eotaxin | 106.0 | 87 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | Eotaxin | 77.0 | 87 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | Eotaxin | 112.5 | 74 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | Eotaxin | 129.0 | 62 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | Eotaxin | 131.0 | 79 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | Eotaxin | 115.0 | 51 | |
N2759 | TNF-a | 100 | ng/mL | 3 | Eotaxin | 117.5 | 56 |